New DNA vaccine aims to wipe out Cancer-Causing HPV infections
NCT ID NCT06210854
First seen Oct 31, 2025 · Last updated May 16, 2026 · Updated 26 times
Summary
This study tests an experimental DNA vaccine called pBI-11 in 48 women with persistent HPV16 or HPV18 infections. The vaccine is designed to boost the immune system to clear these high-risk viruses, which can cause cervical cancer. Participants will receive either the vaccine or a placebo through a special device that helps the DNA enter cells. The main goals are to check safety and see if the vaccine can eliminate the virus.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Alabama at Birmingham
Birmingham, Alabama, 35249, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.